Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101673
Status:
COMPLETED
Last Update Posted:
2012-05-07
First Post:
2005-01-12
Brief Title:
Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2005-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-01-12
First Submit QC Date:
January 12 2005
Study First Post Date:
2005-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-04
Last Update Post Date:
2012-05-07
Last Update Post Date Type:
ESTIMATED